Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 208780

Expand all

ESBRIET (PIRFENIDONE)
267MG
Marketing Status: Prescription
Active Ingredient: PIRFENIDONE
Proprietary Name: ESBRIET
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 267MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N208780
Product Number: 001
Approval Date: Jan 11, 2017
Applicant Holder Full Name: GENENTECH INC
Marketing Status:  Prescription
Patent and Exclusivity Information
ESBRIET (PIRFENIDONE)
801MG
Marketing Status: Prescription
Active Ingredient: PIRFENIDONE
Proprietary Name: ESBRIET
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 801MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N208780
Product Number: 003
Approval Date: Jan 11, 2017
Applicant Holder Full Name: GENENTECH INC
Marketing Status:  Prescription
Patent and Exclusivity Information
ESBRIET (PIRFENIDONE)
534MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Marketing Status: Discontinued
Active Ingredient: PIRFENIDONE
Proprietary Name: ESBRIET
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 534MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N208780
Product Number: 002
Approval Date: Jan 11, 2017
Applicant Holder Full Name: GENENTECH INC
Marketing Status:  Discontinued
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English